Methamphetamine	methamphetamine	S_chemical	O
causes	causes	O	O
alterations	alterations	O	O
in	in	O	O
the	the	O	O
MAP	map	O	O
kinase-related	kinase-related	O	O
pathways	pathways	O	O
in	in	O	O
the	the	O	O
brains	brains	O	O
of	of	O	O
mice	mice	O	O
that	that	O	O
display	display	O	O
increased	increased	O	O
aggressiveness	aggressiveness	O	S_disease
.	.	O	O

Aggressive	aggressive	O	B_disease
behaviors	behaviors	O	I_disease
have	have	O	O
been	been	O	O
reported	reported	O	O
in	in	O	O
patients	patients	O	O
who	who	O	O
suffer	suffer	O	O
from	from	O	O
some	some	O	O
psychiatric	psychiatric	O	B_disease
disorders	disorders	O	I_disease
,	,	O	O
and	and	O	O
are	are	O	O
common	common	O	O
in	in	O	O
methamphetamine	methamphetamine	S_chemical	O
(	(	O	O
METH	meth	S_chemical	O
)	)	O	O
abusers	abusers	O	O
.	.	O	O

Herein	herein	O	O
,	,	O	O
we	we	O	O
report	report	O	O
that	that	O	O
multiple	multiple	O	O
(	(	O	O
but	but	O	O
not	not	O	O
single	single	O	O
)	)	O	O
injections	injections	O	O
of	of	O	O
METH	meth	S_chemical	O
significantly	significantly	O	O
increased	increased	O	O
aggressiveness	aggressiveness	O	S_disease
in	in	O	O
male	male	O	O
CD-1	cd-1	O	O
mice	mice	O	O
.	.	O	O

This	this	O	O
increase	increase	O	O
in	in	O	O
aggressiveness	aggressiveness	O	S_disease
was	was	O	O
not	not	O	O
secondary	secondary	O	O
to	to	O	O
METH-induced	meth-induced	O	O
hyperactivity	hyperactivity	O	S_disease
.	.	O	O

Analysis	analysis	O	O
of	of	O	O
protein	protein	O	O
expression	expression	O	O
using	using	O	O
antibody	antibody	O	O
microarrays	microarrays	O	O
and	and	O	O
Western	western	O	O
blotting	blotting	O	O
revealed	revealed	O	O
differential	differential	O	O
changes	changes	O	O
in	in	O	O
MAP	map	O	O
kinase-related	kinase-related	O	O
pathways	pathways	O	O
after	after	O	O
multiple	multiple	O	O
and	and	O	O
single	single	O	O
METH	meth	S_chemical	O
injections	injections	O	O
.	.	O	O

There	there	O	O
were	were	O	O
statistically	statistically	O	O
significant	significant	O	O
(	(	O	O
p<0.05	p<0.05	O	O
)	)	O	O
decreases	decreases	O	O
in	in	O	O
MEK1	mek1	O	O
,	,	O	O
Erk2p	erk2p	O	O
,	,	O	O
GSK3alpha	gsk3alpha	O	O
,	,	O	O
14	14	O	O
-	-	O	O
3	3	O	O
-	-	O	O
3e	3e	O	O
,	,	O	O
and	and	O	O
MEK7	mek7	S_chemical	O
in	in	O	O
the	the	O	O
striata	striata	S_chemical	O
of	of	O	O
mice	mice	O	O
after	after	O	O
multiple	multiple	O	O
injections	injections	O	O
of	of	O	O
METH	meth	S_chemical	O
.	.	O	O

MEK1	mek1	O	O
was	was	O	O
significantly	significantly	O	O
decreased	decreased	O	O
also	also	O	O
after	after	O	O
a	a	O	O
single	single	O	O
injection	injection	O	O
of	of	O	O
METH	meth	S_chemical	O
,	,	O	O
but	but	O	O
to	to	O	O
a	a	O	O
much	much	O	O
lesser	lesser	O	O
degree	degree	O	O
than	than	O	O
after	after	O	O
multiple	multiple	O	O
injections	injections	O	O
of	of	O	O
METH	meth	S_chemical	O
.	.	O	O

In	in	O	O
the	the	O	O
frontal	frontal	O	O
cortex	cortex	O	O
,	,	O	O
there	there	O	O
was	was	O	O
a	a	O	O
statistically	statistically	O	O
significant	significant	O	O
decrease	decrease	O	O
in	in	O	O
GSK3alpha	gsk3alpha	O	O
after	after	O	O
multiple	multiple	O	O
(	(	O	O
but	but	O	O
not	not	O	O
single	single	O	O
)	)	O	O
injections	injections	O	O
of	of	O	O
METH	meth	S_chemical	O
.	.	O	O

These	these	O	O
findings	findings	O	O
suggest	suggest	O	O
that	that	O	O
alterations	alterations	O	O
in	in	O	O
MAP	map	O	O
kinase-related	kinase-related	O	O
pathways	pathways	O	O
in	in	O	O
the	the	O	O
prefronto-striatal	prefronto-striatal	O	O
circuitries	circuitries	O	O
might	might	O	O
be	be	O	O
involved	involved	O	O
in	in	O	O
the	the	O	O
manifestation	manifestation	O	O
of	of	O	O
aggressive	aggressive	O	B_disease
behaviors	behaviors	O	I_disease
in	in	O	O
mice	mice	O	O
.	.	O	O

